Here are five things to know:
1. Select startup companies developing promising technologies will be candidates to tap into the unique resources established by the creation of the $50 million fund and counsel provided by some of the experts in the ophthalmology field.
2. The Visionary Venture Fund Advisory Board includes more than 20 leaders from among the ophthalmology industry.
3. Board members will help later-stage startup companies navigate the evolution from development and initial funding to commercialization.
4. OCTANe established the fund and board to tap into the ophthalmology growth market.
5. OCTANe drives technology industry growth by connecting ideas and people with resources and capital.
More articles on healthcare:
AmSurg senior director named to ’40 under 40′ list, HCA reports Q4 results & more — 4 key notes on ASC companies
Drs. Rebecca Stark and Jacob Stephenson join Shriners Hospital’s pediatric surgery program — 5 highlights
5 points on urologist compensation
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
